Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	197.57	104.06	165.93	229.82	56.2
Cash & Cash Equivalents	197.57	104.06	165.93	229.82	56.2
Cash Growth	89.86%	-37.28%	-27.80%	308.93%	-7.38%
Receivables	26.18	21.33	21.14	12.25	2.55
Inventory	2.31	1.97	1.25	1.2	0.95
Other Current Assets	6.18	2.26	2.99	2.89	0.47
Total Current Assets	232.24	129.63	191.3	246.16	60.17
Property, Plant & Equipment	18.21	17.9	11.82	13.94	16.81
Other Long-Term Assets	1.61	1.76	1.76	1.76	1.76
Total Long-Term Assets	19.83	19.66	13.59	15.7	18.57
Total Assets	252.06	149.29	204.89	261.86	78.74
Accounts Payable	4.39	5.12	4.59	2.71	3.27
Deferred Revenue	14.39	13.96	13	12	0
Current Debt	1.59	1.6	1.62	9.65	1.13
Other Current Liabilities	14.53	10.71	7.12	2.31	7.64
Total Current Liabilities	34.9	31.4	26.34	26.66	12.03
Long-Term Debt	81.8	62.68	57.36	48.79	58.22
Other Long-Term Liabilities	44.23	19.83	33.19	110.31	12.12
Total Long-Term Liabilities	126.03	82.52	90.55	159.1	70.34
Total Liabilities	160.93	113.91	116.89	185.77	82.37
Total Debt	83.39	64.28	58.98	58.44	59.34
Debt Growth	29.72%	8.99%	0.93%	-1.52%	139.40%
Retained Earnings	-697.58	-616.84	-545.8	-539.25	-383.62
Shareholders' Equity	91.13	35.38	88	76.1	-3.63
Net Cash / Debt	114.18	39.78	106.95	171.38	-3.14
Net Cash / Debt Growth	187.03%	-62.80%	-37.60%	-	-
Net Cash Per Share	1.33	0.48	1.30	2.82	-0.07
Working Capital	197.34	98.23	164.96	219.5	48.14
Book Value Per Share	1.14	0.46	1.15	1.25	-0.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).